皮下注射針市場は、2021年の29億ドルから2031年までに50億ドルを超え、今後数年間、つまり2021〜2031年のCAGRは5.4％になると予想されます。
慢性および生活習慣病の発生の増加、特に世界的な糖尿病有病率の増加、皮下注射針市場の技術開発、および洗練された皮下注射針ソリューションの需要の増加が、市場の拡大を後押しすると予想されます。可処分所得の増加、および新興国における成長の可能性などが今後、皮下注射針の市場に成長機会をもたらすと予想されます。
目次
Contents
1. Executive Summary
2. Global Hypodermic Needles Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. Average Pricing Analysis
5. Macro-Economic Indicators
6. Market Dynamics
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. Correlation & Regression Analysis
7.1. Correlation Matrix
7.2. Regression Matrix
8. Recent Development, Policies & Regulatory Landscape
9. Risk Analysis
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. Global Hypodermic Needles Market Analysis
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. Global Hypodermic Needles Market
11.1. Market Size & forecast, 2020A-2031F
11.1.1. By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
11.1.2. By Volume (Million Units) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12. Global Hypodermic Needles Market: Market Segmentation
12.1. By Regions
12.1.1. North America:(U.S., Mexico, and Canada), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.2. Latin America: (Brazil, Rest of Latin America), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.3. Europe: (Germany, UK, France, Italy, Spain, Rest of Europe), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Australia, Rest of Asia Pacific), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.5. Middle East and Africa: (Saudi Arabia, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2. By Product: Market Share (2020-2031F)
12.2.1. Safety Hypodermic Needles, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2.2. Non-Safety Hypodermic Needles, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3. By Application: Market Share (2020-2031F)
12.3.1. Drug Delivery, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3.2. Vaccination, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3.3. Blood Specimen Collection, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4. End User: Market Share (2020-2031F)
12.4.1. Hospital, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.2. Diabetic Patients, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.3. Family Practitioners, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.4. Psychiatry, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.5. Others, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
13. Company Profile
13.1. Becton, Dickinson and Company
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. B. Braun Melsungen Ag
13.3. Cardinal Health Inc.
13.4. Connecticut Hypodermics Inc.
13.5. Exelint International Co.
13.6. Mckesson Corporation
13.7. Hitech Syringes
13.8. Retractable Technologies, Inc.
13.9. Nipro Corporation
13.10. Terumo Medical Corporation
13.11. Other Prominent Players
14. Consultant Recommendation
15. The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
